| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/21/2000 | WO2000054771A1 The use of 3,5-pyrazolidinedione derivatives to combat viral infections |
| 09/21/2000 | WO2000054730A2 Compositions preparations and uses of human papillomavirus l1 protein |
| 09/21/2000 | WO2000054729A2 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/21/2000 | WO2000040716A3 Soluble receptor br43x2 and methods of using them for therapy |
| 09/21/2000 | WO2000040225A3 Inhibition of tnf activity |
| 09/21/2000 | WO2000039303A3 Modified hiv env polypeptides |
| 09/21/2000 | WO2000038785A3 Methods for treating certain diseases using naaladase inhibitors |
| 09/21/2000 | WO2000027828A3 2,4-disubstituted triazine derivatives with anti hiv activity |
| 09/21/2000 | WO2000026237A3 Chlamydia 98kd putative outer membrane protein and corresponding dna fragments and uses thereof |
| 09/21/2000 | WO2000020598A9 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 09/21/2000 | WO2000016746A9 Immunogenic liposome compositions |
| 09/21/2000 | WO2000012508A3 Pyrrolbenzodiazepines |
| 09/21/2000 | DE19912638A1 Naphthylcarbonsäureamid-substituierte Sulfonamide Naphthylcarbonsäureamid-substituted sulfonamides |
| 09/21/2000 | DE10013017A1 Verfahren zum Läutern eines viralen Antigens und zum Erzeugen eines Impfstoffes A method for refining a viral antigen and for producing a vaccine |
| 09/21/2000 | CA2368068A1 27 human secreted proteins |
| 09/21/2000 | CA2367917A1 Bacterial membrane fractions with adjuvant effect |
| 09/21/2000 | CA2367862A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 09/21/2000 | CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/21/2000 | CA2367409A1 Metering valve |
| 09/21/2000 | CA2367357A1 Method |
| 09/21/2000 | CA2365214A1 Vertebrate protein slit, dna sequence encoding it and uses thereof |
| 09/21/2000 | CA2364739A1 Regulators of intracellular phosphorylation |
| 09/21/2000 | CA2364667A1 Recombinant haemophilus influenzae adhesin proteins |
| 09/21/2000 | CA2364635A1 47 human secreted proteins |
| 09/21/2000 | CA2364568A1 Method for refolding molecules of polypeptides containing ig domains |
| 09/21/2000 | CA2364549A1 50 human secreted proteins |
| 09/20/2000 | EP1036191A2 Method for identifying ihbitors of g-protein coupled receptor hibef51 |
| 09/20/2000 | EP1036188A1 ribG |
| 09/20/2000 | EP1036167A2 Nuclear targeting by means of streptococcal protein h |
| 09/20/2000 | EP1036090A1 Echinocandin derivatives, preparation method and application as anti-fungal agents |
| 09/20/2000 | EP1036084A1 Chemical synthesis of 6-o-alkyl erythromycin c |
| 09/20/2000 | EP1036083A2 NOVEL 3,6-HEMIKETALS FROM THE CLASS OF 9a-AZALIDES |
| 09/20/2000 | EP1036074A1 S-oxide and s,s-dioxide tetrahydrothiopyran phenyloxazolidinones |
| 09/20/2000 | EP1035870A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 09/20/2000 | EP1035868A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation |
| 09/20/2000 | EP1035867A1 Transdermal delivery of particulate vaccine compositions |
| 09/20/2000 | EP1035865A2 Hiv-1 tat, or derivatives thereof for prophylactic and therapeutic vaccination |
| 09/20/2000 | EP1035863A1 An over-expressing homologous antigen vaccine and a method of making the same |
| 09/20/2000 | EP1035861A1 Threonine-containing protegrins |
| 09/20/2000 | EP1035848A1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels |
| 09/20/2000 | EP1035845A1 Modulators of cysteine protease |
| 09/20/2000 | EP1035844A1 The use of polyols in combating yeast infection and polyol preparations for said use |
| 09/20/2000 | EP1035824A1 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs |
| 09/20/2000 | EP0832119B1 Anti-fungal and anti-bacterial histatin-based peptides |
| 09/20/2000 | EP0742834B1 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell |
| 09/20/2000 | EP0579765B1 Method and composition for the treatment of herpes related disorders |
| 09/20/2000 | CN1267330A Method for inactivating virus |
| 09/20/2000 | CN1267306A Cyclopeptide derivs. as adhesion inhibitors |
| 09/20/2000 | CN1266699A Anti-infectious antipyretic and antalgic medicine |
| 09/20/2000 | CN1266680A Application of ursolic acid in medicine for treating viral hepatitis |
| 09/20/2000 | CN1056611C Pyrazolo and pyrrolopyridines, their use and intermidiates for preparing same |
| 09/20/2000 | CN1056520C Anti-senility hypolpemic Chinese medicine liquor |
| 09/20/2000 | CN1056517C Goitre eliminating medicine |
| 09/19/2000 | US6121434 An oligonucleotide diagnostic agent; for the diagnosis and treatment of cancer, restenosis, a nd viral diseases affected by intergrins |
| 09/19/2000 | US6121431 Nucleoside derivatives |
| 09/19/2000 | US6121427 Major outer membrane protein CD of branhamella |
| 09/19/2000 | US6121414 Protein which can be used to screen for antibiotic activity; for prevention of bacterial infections; bactericides |
| 09/19/2000 | US6121375 Gels formed by the interaction of poly(aldehyde) with various substances |
| 09/19/2000 | US6121313 Pharmaceutical composition in a form of self-emulsifying formulation for lipophilic compounds |
| 09/19/2000 | US6121281 Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use |
| 09/19/2000 | US6121259 Olanzapine-N-oxide compositions and methods |
| 09/19/2000 | US6121254 Dermatological/cosmetic compositions comprising antifungal and antibacterial compounds and reduction of hair loss therewith |
| 09/19/2000 | US6121248 Anti-viral agent |
| 09/19/2000 | US6121242 Treatment of bacterial dysentery |
| 09/19/2000 | US6121214 Making a liquid washing product comprising incorporating triclocarban in microencapsulated form into the liquid washing product |
| 09/19/2000 | US6121036 Purified, host-specific, nontoxic, wide host range, virulent preparation against staphylococcus, helicobacter, mycobacterium, streptococcus, klebsiella, enterobacter, proteus, bacteriodes, pseudomonas, escherichia and others |
| 09/19/2000 | US6121028 MurE |
| 09/19/2000 | US6121021 Modified human immunodeficiency virus genome devoid of long terminal repeats, with vpr and tat sequences disabled, and linked to constitutive promoter; for stable, long-term production of nonreplicating immunogens for vaccines |
| 09/19/2000 | US6121018 Polynucleotide which codes for polypeptide of defined amino acid sequence; for therapy and diagnosis of alzheimer's/ parkinson's diseases, multiple sclerosis, amyotrophic lateral sclerosis, septic shock, osteoporosis and other diseases |
| 09/19/2000 | US6120803 Having segment of dosage form that is of sufficient rigidity to withstand contractions of stomach and delay expulsion of dosage form from stomach until substantially all of active agent has been dispensed |
| 09/19/2000 | US6120774 Heterophil-adapted poultry vaccine |
| 09/19/2000 | US6120773 Recombinant herpes simplex viruses vaccines and methods |
| 09/19/2000 | US6120772 Oral drugs for treating AIDS patients |
| 09/19/2000 | US6120771 Isolated polypeptide; diagnosis, therapy |
| 09/19/2000 | US6119687 Partial liquid breathing of fluorocarbons |
| 09/19/2000 | CA2273834A1 Immunomodulator, immunomodulator food and immunomodulator feed |
| 09/19/2000 | CA2079187C Cyclohexapeptidyl bisamine compounds |
| 09/19/2000 | CA2053242C Protease inhibitor |
| 09/14/2000 | WO2000053787A1 Prrsv vaccines |
| 09/14/2000 | WO2000053786A1 Stable recombinant influenza viruses free of helper viruses |
| 09/14/2000 | WO2000053785A2 Method to improve translation of polypeptides by using untranslated regions from heat-shock proteins |
| 09/14/2000 | WO2000053775A2 Prevention and treatment of viral infections |
| 09/14/2000 | WO2000053767A2 Nucleic acid respiratory syncytial virus vaccines |
| 09/14/2000 | WO2000053745A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same |
| 09/14/2000 | WO2000053742A2 Polynucleotides and proteins encoded thereby |
| 09/14/2000 | WO2000053729A2 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 09/14/2000 | WO2000053623A1 Bifunctional molecules for delivery of therapeutics |
| 09/14/2000 | WO2000053610A2 4-OXO-4,7-DIHYDRO-THIENO[2,3-b]PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS |
| 09/14/2000 | WO2000053607A1 Camptothecin derivatives having antitumor activity |
| 09/14/2000 | WO2000053603A1 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents |
| 09/14/2000 | WO2000053600A1 Novel piperidine derivatives |
| 09/14/2000 | WO2000053594A1 Aminomethylpyrrolidine derivatives having aromatic substituents |
| 09/14/2000 | WO2000053591A1 Thiazolyl urea derivatives and their utilization as antiviral agents |
| 09/14/2000 | WO2000053577A1 Hydrazide inhibitors of hiv-1 integrase |
| 09/14/2000 | WO2000053568A1 Sphingoid base derivatives and uses thereof |
| 09/14/2000 | WO2000053223A1 Apoptosis inducing molecule ii and methods of use |
| 09/14/2000 | WO2000053221A1 Intranasal delivery of pneumococcal polysaccharide vaccines |
| 09/14/2000 | WO2000053213A2 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use |
| 09/14/2000 | WO2000053203A1 Anti-hiv agent |
| 09/14/2000 | WO2000053177A1 Liposome preparations |